Procyrion, Inc. is a clinical-stage medical device company based in Houston, Texas, focused on developing circulatory assist devices for heart failure patients. The company's flagship product, Aortix, is a non-surgical catheter-deployed heart pump designed to support patients who cannot rely solely on medication. Aortix addresses the cardiorenal syndrome cycle by being implanted through a catheter in the leg, allowing cardiologists to position it between the heart and kidneys. This innovative device, which is thinner than a pencil, helps to relieve the workload on the heart while ensuring proper blood flow to vital organs. Founded in 2005, Procyrion aims to improve treatment access for heart failure patients, particularly those who are among the most severely affected, as only a small fraction currently receive appropriate interventions.